New Cross Clearance Offers Flexibility in Starting Cattle Rations

Producers can now feed AUREO S 700® with BOVATEC®

 

PARSIPPANY, N.J., September 14, 2020 — Starting cattle on feed has its challenges. With a

recent approval from the Food and Drug Administration, cattle producers now have the flexibility

to add AUREO S 700® into starter and growing rations that contain BOVATEC®.

 

“Cattle producers will see improved gain and feed efficiency, as well as coccidiosis control by

including BOVATEC as the ionophore,” said Gary Sides, PhD, cattle nutritionist, Beef Strategic

Technical Services, Zoetis. “And by adding AUREO S 700, they have the health benefit of

maintaining weight gain in the presence of respiratory disease.” 

 

Dr. Sides adds that it is important for companies to keep up with the needs of cattle producers in

the field and committed to offering additional on-label solutions. He added this cross clearance

allows cattle producers the flexibility to use these products together to raise healthy cattle that

contribute to safe, sustainable food for consumers who enjoy eating beef.

 

For more information on feed additive solutions from Zoetis, visit CattleFeedAdditives.com or

consult with your veterinarian or nutritionist.

 

Withdraw AUREO S 700 seven (7) days prior to slaughter. Do not use in calves to be processed

for veal.

Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD)

drug to use by or on the order of a licensed veterinarian.

 

Do not use BOVATEC in calves to be processed for veal. Do not allow horses or other equines

access to feeds containing lasalocid, as ingestion may be fatal. Feeding undiluted or mixing

errors resulting in excessive concentrations of lasalocid could be fatal to cattle and sheep.

 

About Zoetis

Zoetis is the leading animal health company, dedicated to supporting its customers and their

businesses. Building on more than 65 years of experience in animal health, Zoetis discovers,

develops, manufactures and commercializes medicines, vaccines and diagnostic products,

which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis

serves veterinarians, livestock producers and people who raise and care for farm and

companion animals with sales of its products in more than 100 countries. In 2019, the company

generated annual revenue of $6.3 billion with approximately 10,600 employees. For more

information, visit www.zoetisus.com.